Transposable elements may enhance antiviral resistance in HIV-1 elite controllers

被引:0
|
作者
Singh, Manvendra [1 ,4 ]
Leddy, Sabrina M. [1 ]
Iniguez, Luis Pedro [2 ]
Bendall, Matthew L. [3 ]
Nixon, Douglas F. [3 ,5 ]
Feschotte, Cedric [1 ]
机构
[1] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA
[2] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Barcelona, Spain
[3] Weill Cornell Med, Dept Med, Div Infect Dis, New York, NY 10065 USA
[4] Max Planck Inst Multidisciplinary Sci, Clin Neurosci, City Campus, Gottingen, Germany
[5] Feinstein Inst Med Res, Manhasset, NY 11030 USA
来源
GENOME BIOLOGY | 2025年 / 26卷 / 01期
关键词
Genomics; HIV; Retroviruses; Immunology; Gene regulation; Transposable elements; INNATE IMMUNITY; EVOLUTION; PROTEIN; GENES; DNA; ACTIVATION; INFECTION; APOBEC3G; TRANSCRIPTION; DETERMINANTS;
D O I
10.1186/s13059-025-03484-y
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
BackgroundLess than 0.5% of people living with HIV-1 are elite controllers (ECs)-individuals who maintain undetectable plasma viremia without antiretroviral therapy, despite having replication-competent viral reservoirs. While EC CD4+ T cells have been investigated for gene expression signatures associated with HIV-1 resistance, the expression and regulatory activity of transposable elements (TEs) remain unexplored. TEs can directly impact host immune responses to pathogens, including HIV-1, suggesting their activities could contribute to HIV-1 elite control. To begin testing this hypothesis, we conduct a TE-centric analysis of public multi-omics data from ECs and other populations.ResultsWe find the CD4+ T cell transcriptome and retrotranscriptome of ECs are distinct from healthy controls, from people living with HIV-1 on antiretroviral therapy, and from viremic progressors. However, there is substantial transcriptomic heterogeneity among ECs. We categorize ECs into four clusters with distinct expression and chromatin accessibility profiles of TEs and antiviral factors. Several TE families with known immuno-regulatory activity are differentially expressed among ECs. Their expression positively correlates with their chromatin accessibility in ECs and negatively correlates with the expression of their KRAB zinc-finger (KZNF) repressors. This coordinated, locus-level variation forms a network of putative cis-regulatory elements for genes involved in HIV-1 restriction.ConclusionsWe propose that the EC phenotype is driven in part by reduced KZNF-mediated repression of specific TE-derived cis-regulatory elements for antiviral genes, heightening their resistance against HIV-1. Our study reveals heterogeneity in the EC CD4+ T cell transcriptome, including variable expression of TEs and their KZNF controllers, that must be considered when deciphering HIV-1 control mechanisms.
引用
收藏
页数:29
相关论文
共 50 条
  • [41] Anti-APOBEC3G Activity of HIV-1 Vif Protein Is Attenuated in Elite Controllers
    Kikuchi, Tadashi
    Iwabu, Yukie
    Tada, Takuya
    Kawana-Tachikawa, Ai
    Koga, Michiko
    Hosoya, Noriaki
    Nomura, Shigeru
    Brumme, Zabrina L.
    Jessen, Heiko
    Pereyra, Florencia
    Trocha, Alicja
    Walker, Bruce D.
    Iwamoto, Aikichi
    Tokunaga, Kenzo
    Miura, Toshiyuki
    JOURNAL OF VIROLOGY, 2015, 89 (09) : 4992 - 5001
  • [42] HIV-1 reverse transcriptase and antiviral drug resistance. Part 2
    Das, Kalyan
    Arnold, Eddy
    CURRENT OPINION IN VIROLOGY, 2013, 3 (02) : 119 - 128
  • [43] Differential Gag-Specific Polyfunctional T Cell Maturation Patterns in HIV-1 Elite Controllers
    Ferrando-Martinez, Sara
    Casazza, Joseph P.
    Leal, Manuel
    Machmach, Kawthar
    Angeles Munoz-Fernandez, Ma
    Viciana, Pompeyo
    Koup, Richard A.
    Ruiz-Mateos, Ezequiel
    JOURNAL OF VIROLOGY, 2012, 86 (07) : 3667 - 3674
  • [44] "HIV-1 controllers" - what's their secret?
    Madhavi, V
    Wines, B.
    Emery, S.
    Amin, J.
    Kelleher, A.
    Hogarth, M.
    Stratov, I
    Kent, S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 74 - 74
  • [45] Increased biomarkers of cardiovascular risk in HIV-1 viremic controllers and low persistent inflammation in elite controllers and art-suppressed individuals
    Caetano, Diogo Gama
    Ribeiro-Alves, Marcelo
    Hottz, Eugenio Damaceno
    Vilela, Larissa Melo
    Cardoso, Sandra Wagner
    Hoagland, Brenda
    Grinsztejn, Beatriz
    Veloso, Valdilea Goncalves
    Morgado, Mariza Goncalves
    Bozza, Patricia Torres
    Guimaraes, Monick Lindenmeyer
    Cortes, Fernanda Heloise
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [46] Increased biomarkers of cardiovascular risk in HIV-1 viremic controllers and low persistent inflammation in elite controllers and art-suppressed individuals
    Diogo Gama Caetano
    Marcelo Ribeiro-Alves
    Eugênio Damaceno Hottz
    Larissa Melo Vilela
    Sandra Wagner Cardoso
    Brenda Hoagland
    Beatriz Grinsztejn
    Valdilea Gonçalves Veloso
    Mariza Gonçalves Morgado
    Patrícia Torres Bozza
    Monick Lindenmeyer Guimarães
    Fernanda Heloise Côrtes
    Scientific Reports, 12
  • [47] Control of HIV-1 Replication in Elite Suppressors
    Blankson, Joel N.
    DISCOVERY MEDICINE, 2010, 9 (46) : 261 - 266
  • [48] HIV-1 Infection Induces Potent Type I IFN Signatures in Conventional Dendritic Cells from HIV-1-Elite Controllers
    Martin-Gayo, E.
    Hickman, T.
    Ouyang, Z.
    Pimenova, D.
    Pereyra, F.
    Walker, B. D.
    Lichterfeld, M.
    Yu, X. G.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A18 - A18
  • [49] Viral Characteristics Associated with the Clinical Nonprogressor Phenotype Are Inherited by Viruses from a Cluster of HIV-1 Elite Controllers
    Casado, Concepcion
    Marrero-Hernandez, Sara
    Marquez-Arce, Daniel
    Pernas, Maria
    Marfil, Silvia
    Borras-Granana, Ferran
    Olivares, Isabel
    Cabrera-Rodriguez, Romina
    Valera, Maria-Soledad
    de Armas-Rillo, Laura
    Lemey, Philippe
    Blanco, Julia
    Valenzuela-Fernandez, Agustin
    Lopez-Galindez, Cecilio
    MBIO, 2018, 9 (02):
  • [50] Relationship and clinical significance of soluble markers of inflammation and low-level viraemia in HIV-1 elite controllers
    Li, J. Z.
    Lo, J.
    Dugast, A. S.
    Benedict, K.
    Ribaudo, H. J.
    Cesa, K.
    Heisey, A.
    Kuritzkes, D. R.
    Alter, G.
    Landay, A.
    Grinspoon, S.
    Pereyra, F.
    ANTIVIRAL THERAPY, 2013, 18 : A28 - A28